JP2018500913A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018500913A5 JP2018500913A5 JP2017534913A JP2017534913A JP2018500913A5 JP 2018500913 A5 JP2018500913 A5 JP 2018500913A5 JP 2017534913 A JP2017534913 A JP 2017534913A JP 2017534913 A JP2017534913 A JP 2017534913A JP 2018500913 A5 JP2018500913 A5 JP 2018500913A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- nucleic acid
- cell
- cells
- rnp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cell Anatomy 0.000 claims 36
- 108090000623 proteins and genes Proteins 0.000 claims 29
- 102000004169 proteins and genes Human genes 0.000 claims 27
- 238000000034 method Methods 0.000 claims 25
- 150000007523 nucleic acids Chemical class 0.000 claims 18
- 108020004707 nucleic acids Proteins 0.000 claims 14
- 102000039446 nucleic acids Human genes 0.000 claims 14
- 108010081734 Ribonucleoproteins Proteins 0.000 claims 13
- 102000004389 Ribonucleoproteins Human genes 0.000 claims 13
- 208000031481 Pathologic Constriction Diseases 0.000 claims 6
- 208000037804 stenosis Diseases 0.000 claims 6
- 230000036262 stenosis Effects 0.000 claims 6
- 239000000725 suspension Substances 0.000 claims 5
- 108020004414 DNA Proteins 0.000 claims 4
- 230000014509 gene expression Effects 0.000 claims 4
- 108091079001 CRISPR RNA Proteins 0.000 claims 2
- 108010051219 Cre recombinase Proteins 0.000 claims 2
- 108091027544 Subgenomic mRNA Proteins 0.000 claims 2
- 238000010459 TALEN Methods 0.000 claims 2
- 108091028113 Trans-activating crRNA Proteins 0.000 claims 2
- 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 claims 2
- 108010017070 Zinc Finger Nucleases Proteins 0.000 claims 2
- -1 meganuclease Proteins 0.000 claims 2
- 108091033409 CRISPR Proteins 0.000 claims 1
- 108010008532 Deoxyribonuclease I Proteins 0.000 claims 1
- 102000007260 Deoxyribonuclease I Human genes 0.000 claims 1
- 108020005004 Guide RNA Proteins 0.000 claims 1
- 102000006479 Heterogeneous-Nuclear Ribonucleoproteins Human genes 0.000 claims 1
- 108010019372 Heterogeneous-Nuclear Ribonucleoproteins Proteins 0.000 claims 1
- 108010033040 Histones Proteins 0.000 claims 1
- 102000006947 Histones Human genes 0.000 claims 1
- 108090000621 Ribonuclease P Proteins 0.000 claims 1
- 102000004167 Ribonuclease P Human genes 0.000 claims 1
- 108010003165 Small Nuclear Ribonucleoproteins Proteins 0.000 claims 1
- 102000004598 Small Nuclear Ribonucleoproteins Human genes 0.000 claims 1
- 108010017842 Telomerase Proteins 0.000 claims 1
- 210000000349 chromosome Anatomy 0.000 claims 1
- 230000000536 complexating effect Effects 0.000 claims 1
- 238000010362 genome editing Methods 0.000 claims 1
- 210000005260 human cell Anatomy 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 210000004940 nucleus Anatomy 0.000 claims 1
- 210000003705 ribosome Anatomy 0.000 claims 1
- 150000003384 small molecules Chemical class 0.000 claims 1
- 230000002459 sustained effect Effects 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021087763A JP7857607B2 (ja) | 2015-01-12 | 2021-05-25 | マイクロ流体送達による遺伝子編集 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562102347P | 2015-01-12 | 2015-01-12 | |
| US62/102,347 | 2015-01-12 | ||
| PCT/US2016/013113 WO2016115179A1 (en) | 2015-01-12 | 2016-01-12 | Gene editing through microfluidic delivery |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021087763A Division JP7857607B2 (ja) | 2015-01-12 | 2021-05-25 | マイクロ流体送達による遺伝子編集 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018500913A JP2018500913A (ja) | 2018-01-18 |
| JP2018500913A5 true JP2018500913A5 (enExample) | 2019-02-28 |
| JP7278027B2 JP7278027B2 (ja) | 2023-05-19 |
Family
ID=56406306
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017534913A Active JP7278027B2 (ja) | 2015-01-12 | 2016-01-12 | マイクロ流体送達による遺伝子編集 |
| JP2021087763A Active JP7857607B2 (ja) | 2015-01-12 | 2021-05-25 | マイクロ流体送達による遺伝子編集 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021087763A Active JP7857607B2 (ja) | 2015-01-12 | 2021-05-25 | マイクロ流体送達による遺伝子編集 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US11125739B2 (enExample) |
| EP (1) | EP3245294A4 (enExample) |
| JP (2) | JP7278027B2 (enExample) |
| CN (1) | CN107250373A (enExample) |
| AU (1) | AU2016206870B2 (enExample) |
| WO (1) | WO2016115179A1 (enExample) |
Families Citing this family (91)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013066438A2 (en) | 2011-07-22 | 2013-05-10 | President And Fellows Of Harvard College | Evaluation and improvement of nuclease cleavage specificity |
| WO2013059343A1 (en) | 2011-10-17 | 2013-04-25 | Massachusetts Institute Of Technology | Intracellular delivery |
| US9163284B2 (en) | 2013-08-09 | 2015-10-20 | President And Fellows Of Harvard College | Methods for identifying a target site of a Cas9 nuclease |
| US10124336B2 (en) | 2013-08-16 | 2018-11-13 | Massachusetts Institute Of Technology | Selective delivery of material to cells |
| US9359599B2 (en) | 2013-08-22 | 2016-06-07 | President And Fellows Of Harvard College | Engineered transcription activator-like effector (TALE) domains and uses thereof |
| US9340799B2 (en) | 2013-09-06 | 2016-05-17 | President And Fellows Of Harvard College | MRNA-sensing switchable gRNAs |
| US9322037B2 (en) | 2013-09-06 | 2016-04-26 | President And Fellows Of Harvard College | Cas9-FokI fusion proteins and uses thereof |
| US9526784B2 (en) | 2013-09-06 | 2016-12-27 | President And Fellows Of Harvard College | Delivery system for functional nucleases |
| US20150166984A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting alpha-antitrypsin point mutations |
| AU2015298571B2 (en) | 2014-07-30 | 2020-09-03 | President And Fellows Of Harvard College | Cas9 proteins including ligand-dependent inteins |
| CN122564053A (zh) | 2014-10-31 | 2026-08-14 | 麻省理工学院 | 递送生物分子至免疫细胞 |
| WO2016077761A1 (en) | 2014-11-14 | 2016-05-19 | Massachusetts Institute Of Technology | Disruption and field enabled delivery of compounds and compositions into cells |
| AU2016206870B2 (en) | 2015-01-12 | 2022-02-17 | Massachusetts Institute Of Technology | Gene editing through microfluidic delivery |
| US20180066223A1 (en) | 2015-04-17 | 2018-03-08 | Xcell Biosciences, Inc. | Cancer cell enrichment system |
| JP6925984B2 (ja) | 2015-07-09 | 2021-08-25 | マサチューセッツ インスティテュート オブ テクノロジー | 無核細胞への物質の送達 |
| US11613759B2 (en) | 2015-09-04 | 2023-03-28 | Sqz Biotechnologies Company | Intracellular delivery of biomolecules to cells comprising a cell wall |
| WO2017070632A2 (en) | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| EP3402890B1 (en) * | 2016-01-12 | 2025-01-01 | SQZ Biotechnologies Company | Intracellular delivery of complexes |
| US20190275520A1 (en) | 2016-03-31 | 2019-09-12 | Massachusetts Institute Of Technology | Flow-through microfluidic methods and devices featuring membrane-perturbing surface interactions for intracellular delivery |
| CN109415741A (zh) | 2016-05-03 | 2019-03-01 | Sqz生物技术公司 | 细胞内递送生物分子以诱导耐受性 |
| AU2017302551B2 (en) * | 2016-07-26 | 2023-04-27 | The General Hospital Corporation | Variants of CRISPR from Prevotella and Francisella 1 (Cpf1) |
| WO2018027078A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| AU2017308889B2 (en) | 2016-08-09 | 2023-11-09 | President And Fellows Of Harvard College | Programmable Cas9-recombinase fusion proteins and uses thereof |
| WO2018039084A1 (en) * | 2016-08-20 | 2018-03-01 | The Regents Of The University Of California | High-throughput system and method for the temporary permeablization of cells |
| WO2018039438A1 (en) | 2016-08-24 | 2018-03-01 | President And Fellows Of Harvard College | Incorporation of unnatural amino acids into proteins using base editing |
| WO2018064387A1 (en) * | 2016-09-28 | 2018-04-05 | Novartis Ag | Porous membrane-based macromolecule delivery system |
| US11242542B2 (en) | 2016-10-07 | 2022-02-08 | Integrated Dna Technologies, Inc. | S. pyogenes Cas9 mutant genes and polypeptides encoded by same |
| WO2018068053A2 (en) | 2016-10-07 | 2018-04-12 | Integrated Dna Technologies, Inc. | S. pyogenes cas9 mutant genes and polypeptides encoded by same |
| KR20240007715A (ko) | 2016-10-14 | 2024-01-16 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 핵염기 에디터의 aav 전달 |
| WO2018074980A1 (en) * | 2016-10-21 | 2018-04-26 | Agency For Science, Technology And Research | Device, system and method for intracellular delivery of substances |
| CA3042179A1 (en) * | 2016-10-31 | 2018-05-03 | Seattle Children's Hospital (dba Seattle Children's Research Institute) | Method for treating autoimmune disease using cd4 t-cells with engineered stabilization of expression of endogenous foxp3 gene |
| CA3044101A1 (en) | 2016-11-22 | 2018-05-31 | Integrated Dna Technologies, Inc. | Crispr/cpf1 systems and methods |
| WO2018111947A1 (en) | 2016-12-12 | 2018-06-21 | Integrated Dna Technologies, Inc. | Genome editing enhancement |
| WO2018119359A1 (en) | 2016-12-23 | 2018-06-28 | President And Fellows Of Harvard College | Editing of ccr5 receptor gene to protect against hiv infection |
| JP6994730B2 (ja) * | 2016-12-26 | 2022-02-04 | 独立行政法人酒類総合研究所 | ゲノム編集タンパク質の直接導入による糸状菌ゲノム編集方法 |
| WO2018165504A1 (en) | 2017-03-09 | 2018-09-13 | President And Fellows Of Harvard College | Suppression of pain by gene editing |
| KR20190123328A (ko) | 2017-03-09 | 2019-10-31 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 암 백신 |
| CN110914310A (zh) | 2017-03-10 | 2020-03-24 | 哈佛大学的校长及成员们 | 胞嘧啶至鸟嘌呤碱基编辑器 |
| IL306092A (en) | 2017-03-23 | 2023-11-01 | Harvard College | Nucleic base editors that include nucleic acid programmable DNA binding proteins |
| WO2018195545A2 (en) | 2017-04-21 | 2018-10-25 | The General Hospital Corporation | Variants of cpf1 (cas12a) with altered pam specificity |
| US11560566B2 (en) | 2017-05-12 | 2023-01-24 | President And Fellows Of Harvard College | Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation |
| CA3102054A1 (en) | 2017-06-05 | 2018-12-13 | Fred Hutchinson Cancer Research Center | Genomic safe harbors for genetic therapies in human stem cells and engineered nanoparticles to provide targeted genetic therapies |
| EP3658573A1 (en) | 2017-07-28 | 2020-06-03 | President and Fellows of Harvard College | Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace) |
| WO2019040650A1 (en) | 2017-08-23 | 2019-02-28 | The General Hospital Corporation | GENETICALLY MODIFIED CRISPR-CAS9 NUCLEASES HAVING MODIFIED PAM SPECIFICITY |
| EP3676376B1 (en) | 2017-08-30 | 2025-01-15 | President and Fellows of Harvard College | High efficiency base editors comprising gam |
| CA3082251A1 (en) | 2017-10-16 | 2019-04-25 | The Broad Institute, Inc. | Uses of adenosine base editors |
| US12406749B2 (en) | 2017-12-15 | 2025-09-02 | The Broad Institute, Inc. | Systems and methods for predicting repair outcomes in genetic engineering |
| US11365390B2 (en) | 2017-12-19 | 2022-06-21 | Xcell Biosciences, Inc. | Methods of modulating cell phenotype by way of regulating the gaseous environment |
| EP3749678A1 (en) | 2018-02-07 | 2020-12-16 | Dana Farber Cancer Institute, Inc. | Cell-permeable stapled peptide modules for cellular delivery |
| EP3758687A4 (en) * | 2018-03-01 | 2022-03-30 | Rhode Island Hospital | EXOSOME TARGETING OF CD4+ EXPRESSING CELLS |
| MA52003A (fr) | 2018-03-12 | 2021-01-20 | Sqz Biotechnologies Co | Procédés de traitement de maladies associées au hpv |
| EP3556845A1 (en) | 2018-04-20 | 2019-10-23 | Cellix Limited | A method and device for transfecting cells |
| SG11202007878UA (en) | 2018-04-27 | 2020-09-29 | Seattle Childrens Hospital Dba Seattle Childrens Res Inst | Expression of foxp3 in edited cd34+ cells |
| WO2019226953A1 (en) | 2018-05-23 | 2019-11-28 | The Broad Institute, Inc. | Base editors and uses thereof |
| CN108728330A (zh) * | 2018-06-19 | 2018-11-02 | 东台德缘生物科技有限公司 | 一种用于哺乳动物细胞基因编辑载体构建的试剂盒 |
| EP3820495A4 (en) | 2018-07-09 | 2022-07-20 | The Broad Institute Inc. | RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES |
| CN113165866A (zh) * | 2018-10-04 | 2021-07-23 | Sqz生物技术公司 | 细胞内递送生物分子以增强抗原呈递细胞功能 |
| KR102559149B1 (ko) | 2018-10-26 | 2023-07-24 | 에프. 호프만-라 로슈 아게 | 재조합효소 매개 카세트 교환을 이용한 다중특이적 항체 스크리닝 방법 |
| WO2020092453A1 (en) | 2018-10-29 | 2020-05-07 | The Broad Institute, Inc. | Nucleobase editors comprising geocas9 and uses thereof |
| CN109593743A (zh) * | 2018-12-12 | 2019-04-09 | 广州普世利华科技有限公司 | 新型CRISPR/ScCas12a蛋白及其制备方法 |
| CN109680053A (zh) * | 2018-12-12 | 2019-04-26 | 广州普世利华科技有限公司 | 新型SsCas12a蛋白在核酸检测方面的应用 |
| CN109666662A (zh) * | 2018-12-12 | 2019-04-23 | 广州普世利华科技有限公司 | 新型ScCas12a在核酸检测方面的应用 |
| AU2019403057B2 (en) * | 2018-12-16 | 2026-01-29 | Spinalcyte Llc | Therapeutic uses of gene edited fibroblasts |
| US12351837B2 (en) | 2019-01-23 | 2025-07-08 | The Broad Institute, Inc. | Supernegatively charged proteins and uses thereof |
| BR112021016903A2 (pt) | 2019-02-28 | 2021-11-03 | Sqz Biotechnologies Co | Administração de biomoléculas a pbmcs para modificação de uma resposta imune |
| WO2020191241A1 (en) | 2019-03-19 | 2020-09-24 | The Broad Institute, Inc. | Methods and compositions for editing nucleotide sequences |
| CN113661173B (zh) | 2019-03-29 | 2024-10-01 | 豪夫迈·罗氏有限公司 | 通过以限定的组织形式靶向整合多个表达盒来产生表达FcRn的细胞的方法 |
| WO2020210162A1 (en) | 2019-04-08 | 2020-10-15 | Sqz Biotechnologies Company | Cartridge for use in a system for delivery of a payload into a cell |
| WO2020207456A1 (en) * | 2019-04-11 | 2020-10-15 | The Chinese University Of Hong Kong | Systems and methods for controlled membrane disruption |
| WO2020214842A1 (en) | 2019-04-17 | 2020-10-22 | The Broad Institute, Inc. | Adenine base editors with reduced off-target effects |
| WO2020252215A1 (en) | 2019-06-12 | 2020-12-17 | Cellfe, Inc. | Methods and systems for cell labeling and imaging |
| JP7689949B2 (ja) | 2019-10-03 | 2025-06-09 | アーティサン ディベロップメント ラブズ インコーポレイテッド | 操作されたデュアルガイド核酸を有するｃｒｉｓｐｒシステム |
| US12435330B2 (en) | 2019-10-10 | 2025-10-07 | The Broad Institute, Inc. | Methods and compositions for prime editing RNA |
| WO2021095012A1 (en) * | 2019-11-13 | 2021-05-20 | Crispr Therapeutics Ag | Methods of manufacturing car-t cells |
| AU2020382219A1 (en) * | 2019-11-13 | 2022-05-12 | Crispr Therapeutics Ag | Manufacturing process for making T cells expressing chimeric antigen receptors |
| EP4065701A4 (en) * | 2019-11-27 | 2023-11-29 | Danmarks Tekniske Universitet | CONSTRUCTS, COMPOSITIONS AND METHODS THEREOF WITH IMPROVED GENOMEDITING EFFICIENCY AND SPECIFICITY |
| EP4093864A4 (en) | 2020-01-24 | 2024-04-10 | The General Hospital Corporation | Unconstrained genome targeting with near-pamless engineered crispr-cas9 variants |
| WO2021151085A2 (en) | 2020-01-24 | 2021-07-29 | The General Hospital Corporation | Crispr-cas enzymes with enhanced on-target activity |
| WO2021213479A1 (zh) * | 2020-04-22 | 2021-10-28 | 复星凯特生物科技有限公司 | Shp2特异性失活突变蛋白及其在car-t治疗中应用 |
| CA3177481A1 (en) | 2020-05-08 | 2021-11-11 | David R. Liu | Methods and compositions for simultaneous editing of both strands of a target double-stranded nucleotide sequence |
| IL302976A (en) | 2020-11-18 | 2023-07-01 | Cellfe Inc | Mechanoporation-based methods and systems for high-throughput charge transfer into biological cells |
| US12227729B2 (en) | 2020-12-24 | 2025-02-18 | Cellfe, Inc. | Methods and systems for high-throughput cell processing |
| CN116670265B (zh) | 2020-12-29 | 2026-08-04 | 加拿大干细胞技术公司 | 用于扰动细胞膜的具有并行缩窄部的高通量微流控芯片 |
| AU2022227650A1 (en) | 2021-02-25 | 2023-10-12 | Celyntra Therapeutics Sa | Compositions and methods for targeting, editing, or modifying genes |
| EP4337769A1 (en) * | 2021-05-10 | 2024-03-20 | SQZ Biotechnologies Company | Methods for delivering genome editing molecules to the nucleus or cytosol of a cell and uses thereof |
| WO2022256448A2 (en) | 2021-06-01 | 2022-12-08 | Artisan Development Labs, Inc. | Compositions and methods for targeting, editing, or modifying genes |
| CA3223311A1 (en) | 2021-06-18 | 2022-12-22 | Andrea BARGHETTI | Compositions and methods for targeting, editing or modifying human genes |
| EP4486881A1 (en) | 2022-03-01 | 2025-01-08 | Celyntra Therapeutics SA | Composition and methods for transgene insertion |
| EP4526884A2 (en) | 2022-05-20 | 2025-03-26 | Artisan Development Labs, Inc. | Systems and methods for assessing risk of genome editing events |
| WO2024062138A1 (en) | 2022-09-23 | 2024-03-28 | Mnemo Therapeutics | Immune cells comprising a modified suv39h1 gene |
| EP4619534A2 (en) * | 2022-11-16 | 2025-09-24 | Mammoth Biosciences, Inc. | Effector proteins, compositions, systems and methods of use thereof |
Family Cites Families (125)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2502621C3 (de) | 1975-01-23 | 1978-09-14 | Kernforschungsanlage Juelich Gmbh, 5170 Juelich | Messung elastischer und dielektrischer Eigenschaften der Membran lebender Zellen |
| US4376634A (en) | 1980-05-30 | 1983-03-15 | Mallinckrodt, Inc. | Assay kit having syringe, dilution device and reagents within sealed container |
| US4478824A (en) | 1983-08-08 | 1984-10-23 | Franco Robert S | Method for altering red blood cell function and survival |
| FR2569477B1 (fr) | 1984-08-24 | 1987-01-02 | Descartes Universite Rene | Appareil et procede pour la determination de la deformabilite des globules rouges du sang |
| JP2720161B2 (ja) | 1988-02-01 | 1998-02-25 | 株式会社アドバンス | 細胞変形能測定装置 |
| JP2685544B2 (ja) | 1988-11-11 | 1997-12-03 | 株式会社日立製作所 | 血液フィルタおよび血液検査方法並びに血液検査装置 |
| JP2532707B2 (ja) | 1990-03-08 | 1996-09-11 | 佑二 菊池 | 血液回路及びこれを用いた血液測定装置及び血液測定方法 |
| ATE162402T1 (de) | 1990-04-24 | 1998-02-15 | Flustat Pty Ltd | Oraler an der oberfläche von erythrozyten gebundene antigene beinhaltender impfstoff |
| US5658892A (en) | 1993-01-15 | 1997-08-19 | The General Hospital Corporation | Compound delivery using high-pressure impulse transients |
| US6218166B1 (en) | 1994-12-09 | 2001-04-17 | John Wayne Cancer Institute | Adjuvant incorporation into antigen carrying cells: compositions and methods |
| WO1996027392A1 (en) | 1995-03-08 | 1996-09-12 | The Scripps Research Institute | Antigen presenting system and methods for activation of t-cells |
| US6051409A (en) * | 1995-09-25 | 2000-04-18 | Novartis Finance Corporation | Method for achieving integration of exogenous DNA delivered by non-biological means to plant cells |
| US6133503A (en) * | 1995-10-31 | 2000-10-17 | The Regents Of The University Of California | Mammalian artificial chromosomes and methods of using same |
| EP0874635B1 (en) | 1995-12-04 | 2003-03-19 | Puget Sound Blood Center | Nonimmunogenic platelet and red blood cell compositions |
| AU734196B2 (en) | 1996-03-28 | 2001-06-07 | Whitehead Institute | Opsonin-enhanced cells, and methods of modulating an immune response to an antigen |
| US5885470A (en) | 1997-04-14 | 1999-03-23 | Caliper Technologies Corporation | Controlled fluid transport in microfabricated polymeric substrates |
| EP0882448B1 (en) | 1997-05-05 | 2005-01-12 | DIDECO S.r.l. | Method of encapsulating biologically active agents within erythrocytes and apparatus therefor |
| US5842787A (en) | 1997-10-09 | 1998-12-01 | Caliper Technologies Corporation | Microfluidic systems incorporating varied channel dimensions |
| SE9704076D0 (sv) | 1997-11-06 | 1997-11-06 | Holdingbolaget Vid Goeteborgs | Method for permeabilisation of cell structures and use thereof |
| GB9816583D0 (en) | 1998-07-31 | 1998-09-30 | Univ Ulster | Nucleic acid carrier |
| AU5757100A (en) | 1999-06-21 | 2001-01-09 | General Hospital Corporation, The | Methods and devices for cell culturing and organ assist systems |
| JP2002325572A (ja) | 2000-12-25 | 2002-11-12 | Univ Osaka | 外来物質の導入方法 |
| AU2002252073A1 (en) | 2001-02-22 | 2002-09-12 | The Scepens Eye Research Institute, Inc. | Tolerogenic antigen presenting cells and in treating immune-inflammatory conditions |
| WO2003020039A1 (en) | 2001-08-28 | 2003-03-13 | Rush-Presbyterian-St. Luke's Medical Center | Immune tolerance to predetermined antigens |
| AU2002353741A1 (en) | 2001-11-27 | 2003-06-10 | Cellectricon Ab | A method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| US20030133922A1 (en) | 2002-01-15 | 2003-07-17 | Kasha John R. | Oral tolerance using allogeneic platelets in ITP |
| WO2003104788A1 (ja) | 2002-06-05 | 2003-12-18 | 松下電器産業株式会社 | 細胞外電位測定デバイスおよびその製造方法 |
| GB0214528D0 (en) | 2002-06-24 | 2002-08-07 | Univ Aberdeen | Materials and methods for induction of immune tolerance |
| CA2513072A1 (en) | 2003-01-09 | 2004-07-29 | Invitrogen Corporation | Cellular delivery and activation polypeptide-nucleic acid complexes |
| US20060134067A1 (en) | 2003-02-18 | 2006-06-22 | Maxcyte, Inc. | Loading of cells with antigens by electroporation |
| EP1780266A4 (en) | 2004-06-17 | 2009-09-09 | Ken Nakata | CELL CULTIVATION PROCESS WITH BIOMECHANICAL LOAD TREATMENT AND ITS DEVICE |
| CN1981073B (zh) | 2004-07-27 | 2011-07-13 | 帝斯曼知识产权资产管理有限公司 | 用于制备碳纳米管/超高摩尔质量聚乙烯复合纤维的方法 |
| FR2873925B1 (fr) | 2004-08-05 | 2006-10-13 | Erytech Pharma Soc Par Actions | Procede et dispositif de lyse-rescellement pour l'incorporation de principe actif notamment asparaginase ou inositol hexaphosphate, dans des erythrocytes |
| CN100591761C (zh) | 2004-08-19 | 2010-02-24 | 加的夫大学学院咨询有限公司 | 呈递抗原的人γδT细胞的制备和在免疫治疗中的用途 |
| US20060134772A1 (en) | 2004-11-18 | 2006-06-22 | The Regents Of The University Of California | System for locating cells and for cellular analysis |
| WO2006095330A2 (en) | 2005-03-10 | 2006-09-14 | Yeda Research And Development Co. Ltd. | Methods and immunogenic cell preparations for treating antigen-associated diseases |
| US7704743B2 (en) | 2005-03-30 | 2010-04-27 | Georgia Tech Research Corporation | Electrosonic cell manipulation device and method of use thereof |
| KR100760309B1 (ko) | 2005-07-06 | 2007-10-05 | 한국과학기술원 | 미소필터를 이용한 미소입자 변형성 분석기 |
| US7993821B2 (en) | 2005-08-11 | 2011-08-09 | University Of Washington | Methods and apparatus for the isolation and enrichment of circulating tumor cells |
| US9005974B2 (en) | 2005-12-09 | 2015-04-14 | Academish Medisch Centrum Bij De Universiteit Van Amsterdam | Means and methods for influencing the stability of cells |
| WO2007097934A2 (en) | 2006-02-17 | 2007-08-30 | Elusys Therapeutics, Inc. | Methods and compositions for using erythrocytes as carriers for delivery of drugs |
| US8293524B2 (en) | 2006-03-31 | 2012-10-23 | Fluxion Biosciences Inc. | Methods and apparatus for the manipulation of particle suspensions and testing thereof |
| US20070249038A1 (en) | 2006-04-21 | 2007-10-25 | Andrea Adamo | Microfluidic device for single cell targeted operations |
| AU2007284454A1 (en) | 2006-08-17 | 2008-02-21 | Massachusetts Institute Of Technology | Method and apparatus for microfluidic injection |
| US20080241844A1 (en) | 2007-02-06 | 2008-10-02 | Network Biosystems, Inc. | Devices and Methods for the Performance of Miniaturized In Vitro Assays |
| US20080311140A1 (en) | 2007-05-29 | 2008-12-18 | Baylor College Of Medicine | Antigen specific immunosuppression by dendritic cell therapy |
| US8841135B2 (en) | 2007-06-20 | 2014-09-23 | University Of Washington | Biochip for high-throughput screening of circulating tumor cells |
| EP2169070B1 (en) | 2007-06-21 | 2015-06-10 | National University Corporation Nagoya University | Method for introducing foreign substance into cell having cell wall |
| FR2919804B1 (fr) | 2007-08-08 | 2010-08-27 | Erytech Pharma | Composition et vaccin therapeutique anti-tumoral |
| GB0718160D0 (en) | 2007-09-18 | 2007-10-24 | Medical Res Council | Methods |
| EP2057998A1 (en) | 2007-10-31 | 2009-05-13 | Universitätsklinikum Hamburg-Eppendorf | Use of modified cells for the treatment of multiple sclerosis |
| KR100891487B1 (ko) | 2007-11-01 | 2009-04-01 | 한국과학기술원 | 미세유체제어기술 기반으로 한 난모세포 또는 난자의 핵제거 시스템 |
| CN101874201B (zh) | 2007-11-28 | 2012-08-15 | 柯尼卡美能达精密光学株式会社 | 血液流动性测量装置及血液流动性测量方法 |
| US20090280518A1 (en) | 2008-05-12 | 2009-11-12 | Massachusetts Institute Of Technology | System for high throughput measurement of mechanical properties of cells |
| JP2010002582A (ja) | 2008-06-19 | 2010-01-07 | Konica Minolta Business Technologies Inc | 画像形成装置 |
| JP5137129B2 (ja) | 2008-07-23 | 2013-02-06 | 国立大学法人山口大学 | 血液細胞の力学的特性測定装置 |
| EP2321405A4 (en) | 2008-08-08 | 2012-09-12 | Agency Science Tech & Res | MICROFLUIDIC CONTINUOUS FLOW DEVICE |
| US8211656B2 (en) | 2008-08-13 | 2012-07-03 | The Invention Science Fund I, Llc | Biological targeting compositions and methods of using the same |
| US20110091973A1 (en) | 2008-12-09 | 2011-04-21 | Glaser Larry F | Modified and fusion enhanced erythrocytes, cells and uses thereof |
| US9157550B2 (en) | 2009-01-05 | 2015-10-13 | The Board Of Trustees Of The University Of Illinois | Microfluidic systems and methods |
| EP2405959A4 (en) | 2009-03-13 | 2013-10-16 | Univ Tufts | METHODS, DEVICES AND KITS FOR INTRODUCING GENETIC MATERIAL IN LIVING CELLS |
| US9017991B2 (en) | 2009-03-13 | 2015-04-28 | Tufts University | Methods tip assemblies and kits for introducing material into cells |
| US20120107925A1 (en) | 2009-03-20 | 2012-05-03 | Mo Huang Li | Devices for separating cells and methods of using them |
| JP4849278B2 (ja) | 2009-03-27 | 2012-01-11 | セイコーエプソン株式会社 | 細胞処理デバイス、細胞処理カートリッジおよび体液処理システム |
| WO2010129671A2 (en) | 2009-05-08 | 2010-11-11 | Chauncey Sayre | Method of and apparatus for changing one type of cell into another type of cell |
| GB0909754D0 (en) | 2009-06-05 | 2009-07-22 | Magnani Mauro | Drug delivery systems |
| EP2449135B1 (en) | 2009-06-30 | 2016-01-06 | Sangamo BioSciences, Inc. | Rapid screening of biologically active nucleases and isolation of nuclease-modified cells |
| EP2451475A2 (en) | 2009-07-06 | 2012-05-16 | Novartis AG | Self replicating rna molecules and uses thereof |
| KR101125060B1 (ko) | 2009-07-22 | 2012-03-21 | 한국과학기술원 | 입자를 포획하는 미세유체 소자 및 이를 이용한 입자 포획 방법 |
| US9364831B2 (en) | 2009-08-08 | 2016-06-14 | The Regents Of The University Of California | Pulsed laser triggered high speed microfluidic switch and applications in fluorescent activated cell sorting |
| ES2600932T3 (es) | 2009-10-27 | 2017-02-13 | Erytech Pharma | Composición para inducir una tolerancia inmunitaria específica |
| US20130023051A1 (en) | 2009-12-21 | 2013-01-24 | Keygene N.V. | Techniques for transfecting protoplasts |
| EP2516320A4 (en) | 2009-12-23 | 2015-03-04 | Cytovera Inc | SYSTEM AND METHOD FOR PARTICLE FILTRATION |
| WO2011084882A2 (en) | 2010-01-05 | 2011-07-14 | Contrafect Corporation | Methods and compositions for enhanced immunological therapy and targeting of gram-positive bacteria |
| US8844570B2 (en) * | 2010-02-01 | 2014-09-30 | California Institute Of Technology | Generating binary states using a microfluidic channel |
| JP5704590B2 (ja) | 2010-02-05 | 2015-04-22 | 国立大学法人東京農工大学 | サイズ選択マイクロキャビティアレイを用いた循環腫瘍細胞の検出 |
| US9458489B2 (en) | 2010-03-04 | 2016-10-04 | Massachusetts Institute Of Technology | Microfluidics sorter for cell detection and isolation |
| US20110289043A1 (en) | 2010-03-22 | 2011-11-24 | Brown University Research Foundation | Computational methods and compositions |
| KR20130100290A (ko) | 2010-08-30 | 2013-09-10 | 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 | 협착성 병변을 위한 전단 제어 방출 및 혈전 용해 치료법 |
| US10023847B2 (en) | 2010-11-25 | 2018-07-17 | Imnate Sarl | Immunogenic peptides for use in the prevention and/or treatment of infectious diseases, autoimmune diseases, immune responses to allofactors, allergic diseases, tumors, graft rejection and immune responses against viral vectors used for gene therapy or gene vaccination |
| CA2825093A1 (en) | 2011-01-19 | 2012-07-26 | The University Of British Columbia | Apparatus and method for particle separation |
| MX363013B (es) | 2011-02-25 | 2019-03-04 | Recombinetics Inc | Animales genéticamente modificados y métodos para su obtención. |
| EP2681306B1 (en) | 2011-02-28 | 2019-01-09 | President and Fellows of Harvard College | Cell culture system |
| CN116179323A (zh) | 2011-05-27 | 2023-05-30 | 不列颠哥伦比亚大学 | 用于高通量分析的微流控细胞捕获和分析设备 |
| HRP20141230T1 (hr) | 2011-07-05 | 2015-02-13 | SOTIO a.s. | Naäśini i postupci aktivne staniäśne imunoterapije raka upotrebom tumorskih stanica usmrä†enih visokim hidrostatskim tlakom, te dendritiäśkih stanica |
| US20130065314A1 (en) | 2011-08-25 | 2013-03-14 | Phytocentric Biotech Inc. | Algal transformation systems, compositions and methods |
| WO2013059343A1 (en) * | 2011-10-17 | 2013-04-25 | Massachusetts Institute Of Technology | Intracellular delivery |
| CN104684546A (zh) | 2012-06-07 | 2015-06-03 | 哈佛大学校长及研究员协会 | 用于药物靶向的纳米疗法 |
| US9255245B2 (en) | 2012-07-03 | 2016-02-09 | Agilent Technologies, Inc. | Sample probes and methods for sampling intracellular material |
| EP4397759A3 (en) | 2012-10-23 | 2024-10-09 | Toolgen Incorporated | Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof |
| CN102925337B (zh) | 2012-11-08 | 2014-06-18 | 武汉友芝友生物制药有限公司 | 一种微流体细胞捕获芯片及其制备方法 |
| US8697359B1 (en) * | 2012-12-12 | 2014-04-15 | The Broad Institute, Inc. | CRISPR-Cas systems and methods for altering expression of gene products |
| GB201300052D0 (en) | 2013-01-03 | 2013-02-20 | Transimmune Ag | Method for obtaining immuno-suppressive dendritic cells |
| GB201300049D0 (en) | 2013-01-03 | 2013-02-20 | Transimmune Ag | Method for obtaining immuno-stimulatory dendritic cells |
| WO2014120956A1 (en) | 2013-01-30 | 2014-08-07 | Asta Fluidic Technologies, Inc. | Microfluidic-based fetal red blood cell detection |
| US9725709B2 (en) | 2013-03-12 | 2017-08-08 | OpenCell Technologies, Inc. | Intracellular delivery and transfection methods and devices |
| WO2014151888A1 (en) | 2013-03-15 | 2014-09-25 | The Regents Of The University Of California | High-throughput cargo delivery into live cells using photothermal platforms |
| KR20140115560A (ko) | 2013-03-21 | 2014-10-01 | 인하대학교 산학협력단 | 기계적 스트레스를 이용한 단세포 생물체 개질 방법 및 이에 사용되는 장치 |
| EP3789487A1 (en) | 2013-04-03 | 2021-03-10 | Memorial Sloan Kettering Cancer Center | Effective generation of tumor-targeted t-cells derived from pluripotent stem cells |
| KR101508974B1 (ko) | 2013-05-14 | 2015-04-07 | 한국과학기술연구원 | 종양 세포의 검출장치 및 검출방법 |
| US10124336B2 (en) | 2013-08-16 | 2018-11-13 | Massachusetts Institute Of Technology | Selective delivery of material to cells |
| CA2927947A1 (en) | 2013-10-22 | 2015-04-30 | Cellanyx Diagnostics, Llc | Systems, devices and methods for microfluidic culturing, manipulation and analysis of tissues and cells |
| US10137673B2 (en) | 2013-12-31 | 2018-11-27 | Canon U.S. Life Sciences, Inc. | Methods and systems for continuous flow cell lysis in a microfluidic device |
| CN106456744A (zh) | 2014-04-01 | 2017-02-22 | 鲁比厄斯治疗法股份有限公司 | 用于免疫调节的方法和组合物 |
| SG11201608701QA (en) | 2014-04-18 | 2016-11-29 | Editas Medicine Inc | Crispr-cas-related methods, compositions and components for cancer immunotherapy |
| WO2016003485A1 (en) | 2014-07-03 | 2016-01-07 | Massachusetts Institute Of Technology | Microfluidic assay for rapid optimization of cell electroporation |
| CN122564053A (zh) | 2014-10-31 | 2026-08-14 | 麻省理工学院 | 递送生物分子至免疫细胞 |
| WO2016077761A1 (en) | 2014-11-14 | 2016-05-19 | Massachusetts Institute Of Technology | Disruption and field enabled delivery of compounds and compositions into cells |
| WO2016094715A2 (en) | 2014-12-10 | 2016-06-16 | Berkeley Lights, Inc. | Movement and selection of micro-objects in a microfluidic apparatus |
| EP3242946B1 (en) | 2015-01-07 | 2026-08-19 | Indee. Inc. | A method for mechanical and hydrodynamic microfluidic transfection and apparatus therefor |
| AU2016206870B2 (en) | 2015-01-12 | 2022-02-17 | Massachusetts Institute Of Technology | Gene editing through microfluidic delivery |
| WO2016183482A1 (en) | 2015-05-13 | 2016-11-17 | Rubius Therapeutics, Inc. | Membrane-receiver complex therapeutics |
| GB201513278D0 (en) | 2015-07-03 | 2015-09-09 | Transimmune Ag And Yale University | Device and method for obtaining immunostimulatory antigen-presenting cells |
| JP6925984B2 (ja) | 2015-07-09 | 2021-08-25 | マサチューセッツ インスティテュート オブ テクノロジー | 無核細胞への物質の送達 |
| US20190382796A1 (en) | 2015-09-04 | 2019-12-19 | Sqz Biotechnologies Company | Intracellular delivery of biomolecules mediated by a surface with pores |
| US11613759B2 (en) | 2015-09-04 | 2023-03-28 | Sqz Biotechnologies Company | Intracellular delivery of biomolecules to cells comprising a cell wall |
| AU2016374643B2 (en) | 2015-12-22 | 2023-12-14 | Sangui Bio Pty. Ltd | Therapeutic methods using erythrocytes |
| CN108697733A (zh) | 2016-01-11 | 2018-10-23 | 鲁比厄斯治疗法股份有限公司 | 与癌症适应症的多模式治疗性细胞体系有关的组合物和方法 |
| EP3402890B1 (en) | 2016-01-12 | 2025-01-01 | SQZ Biotechnologies Company | Intracellular delivery of complexes |
| JP2019518009A (ja) | 2016-05-03 | 2019-06-27 | スクイーズ バイオテクノロジーズ カンパニー | 寛容性を誘導するための生体分子の細胞内送達 |
| CN109415741A (zh) | 2016-05-03 | 2019-03-01 | Sqz生物技术公司 | 细胞内递送生物分子以诱导耐受性 |
| US20170326213A1 (en) | 2016-05-16 | 2017-11-16 | Augusta University Research Institute, Inc. | Protein-Coupled Red Blood Cell Compositions and Methods of Their Use |
| CN106244543A (zh) | 2016-07-29 | 2016-12-21 | 北京时合生物科技有限公司 | 一种pbmc体外诱导分化成为树突状细胞的方法 |
| WO2018089497A1 (en) | 2016-11-08 | 2018-05-17 | Georgia Tech Research Corporation | Methods for convectively-driven intracellular delivery |
| US20230130686A1 (en) | 2021-10-25 | 2023-04-27 | Massachusetts Institute Of Technology | Devices and systems for delivery of materials to cells |
-
2016
- 2016-01-12 AU AU2016206870A patent/AU2016206870B2/en active Active
- 2016-01-12 EP EP16737769.6A patent/EP3245294A4/en active Pending
- 2016-01-12 US US15/542,892 patent/US11125739B2/en active Active
- 2016-01-12 CN CN201680008278.0A patent/CN107250373A/zh active Pending
- 2016-01-12 JP JP2017534913A patent/JP7278027B2/ja active Active
- 2016-01-12 WO PCT/US2016/013113 patent/WO2016115179A1/en not_active Ceased
-
2021
- 2021-05-25 JP JP2021087763A patent/JP7857607B2/ja active Active
- 2021-08-17 US US17/404,286 patent/US12130281B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20250154588A1 (en) | Methods for determining a location of a biological analyte in a biological sample | |
| US12385083B2 (en) | Methods of using master / copy arrays for spatial detection | |
| Shi et al. | A review on electroporation-based intracellular delivery | |
| BR112021012665A2 (pt) | Polipeptídeos úteis para edição de genes e métodos de uso | |
| JP6886404B2 (ja) | 初代造血細胞におけるタンパク質送達 | |
| JP2021129584A (ja) | マイクロ流体送達による遺伝子編集 | |
| WO2017004279A3 (en) | Compositions comprising nucleic acids and methods of using the same | |
| WO2017070632A3 (en) | Nucleobase editors and uses thereof | |
| WO2017180694A8 (en) | Cas9 fusion molecules, gene editing systems, and methods of use thereof | |
| WO2017027423A9 (en) | Engineered crispr-cas9 compositions and methods of use | |
| JP2017537615A5 (enExample) | ||
| US12529094B2 (en) | Imaging system hardware | |
| WO2017216771A3 (en) | Crispr-cas system, materials and methods | |
| BR112022002695A2 (pt) | Nucleases guiadas por rna, fragmentos ativos e variantes das mesmas e métodos de uso | |
| US20230183786A1 (en) | Methods for identifying and modulating co-occurant cellular phenotypes | |
| JP2017533702A5 (enExample) | ||
| BR112015023108A2 (pt) | sistema de acondicionamento de célula bacteriana, método para acondicionamento de uma molécula de ácido nucléico repórter, composição e método para detectar uma presença ou uma ausência de uma célula bacteriana em uma amostra | |
| EP4310196A3 (en) | Methods and compositions for manipulating nucleic acids | |
| IL295858B1 (en) | gRNA molecules including TRACR and crRNA, compositions containing them and their use | |
| FI3604532T3 (fi) | Uusia crispr-entsyymejä ja järjestelmiä | |
| FI3599251T3 (fi) | Cd20-antigeeniin kohdentuvan kimeerisen antigeenireseptorin rakentaminen ja sillä muunnettujen t-solujen aktiivisuuden tunnistaminen | |
| WO2015157579A3 (en) | Enhanced nucleic acid constructs for eukaryotic gene expression | |
| CA3048645A1 (en) | Methods for selection and generation of genome edited t cells | |
| WO2019090160A3 (en) | Compositions and methods of use thereof for the treatment of duchenne muscular dystrophy | |
| WO2005111240A3 (en) | Field-switch sequencing |